Request Demo
Last update 02 Nov 2026
Lanzhou Bailing Biotechnology Co., Ltd.
Last update 02 Nov 2026
Overview
Tags
Respiratory Diseases
Infectious Diseases
Prophylactic vaccine
Multivalent vaccine
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
No Data
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
CTR20261447
评价四价流感病毒裂解疫苗（MDCK细胞）在3周岁及以上人群中接种的安全性的随机、盲法、安慰剂对照Ⅰ期临床试验
[Translation] A randomized, blinded, placebo-controlled phase I clinical trial evaluating the safety of quadrivalent influenza virus split vaccine (MDCK cell) in individuals aged 3 years and older.
CTR20261446
评价三价流感病毒裂解疫苗（MDCK细胞）在3周岁及以上人群中接种的安全性和初步免疫原性的随机、盲法、阳性对照Ⅰ期临床试验
[Translation] A randomized, blinded, positive-controlled phase I clinical trial evaluating the safety and preliminary immunogenicity of trivalent influenza virus split vaccine (MDCK cell) in individuals aged 3 years and older.
CTR20254267
评价四价流感病毒裂解疫苗（MDCK细胞）在3岁及以上人群中接种的免疫原性和安全性的随机、盲法、阳性对照IIIa期临床试验
[Translation] A randomized, blinded, positive-controlled phase IIIa clinical trial evaluating the immunogenicity and safety of a quadrivalent influenza virus split vaccine (MDCK cell) in individuals aged 3 years and older.
100 Clinical Results associated with Lanzhou Bailing Biotechnology Co., Ltd.
Login to view more data
Login to view more data
100 Deals associated with Lanzhou Bailing Biotechnology Co., Ltd.
Login to view more data
100 Translational Medicine associated with Lanzhou Bailing Biotechnology Co., Ltd.
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 05 Nov 2026
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
IND Approval
4
2
Phase 1
Phase 3
1
1
Other
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free